Category: Clinical Trials

In the relentless battle against cancer, advancements in personalized medicine are shaping a new frontier of hope and resilience.

New Drug Crosses Blood-brain Barrier and kills glioblastoma cells A team led by Dr. Priya Kumthekar of Northwestern University, a long-time Head for the Cure and Brains for the Cure partner, has published a study …

The Ivy Brain Tumor Center at Barrow Neurological Institute announced the treatment of their first patient in a Phase 0 clinical trial for newly diagnosed glioblastoma and recurrent glioblastoma. This trial is investigating Pamiparib’s effect on crossing …

OncoSynergy, Inc. launched the company’s First-in-Human Phase 1 clinical trial evaluating a treatment of recurrent glioblastoma. Today they announced the first patient has been treated in this trial using OS2966, a first-in-class immunotherapy, and the …

Dr. John Boockvar, a Head for the Cure partner on our New York–area events and one of the subjects of the medical docu-drama Lenox Hill on Netflix, has recently begun the Phase 1 trial of …

In a global clinical trial, GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment), Henry Ford Cancer Institute is the first to activate two new treatments for glioblastoma. The GBM AGILE trial allows for global collaboration …

Brains for the Cure’s writers review several important developments in recent pediatric brain tumor research.

The website ClinicalTrials.gov is one that that patients and families fighting brain tumors should be familiar with. Knowing how to use the site yourself or with the help of staff from the cancer center where …

A team at Henry Ford Health System has published encouraging findings for using radiosurgery to treat for recurrent brain tumors.

Novocure and GT Medical Technologies continue to move forward and make progress in their research to creating a better quality of life for patients and improving survival rates.